# Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

> **NCT04609280** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 52 (actual)

## Conditions studied

- Head and Neck Cancer
- Oropharynx Cancer
- Oropharyngeal Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)

## Key facts

- **NCT ID:** NCT04609280
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04609280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04609280, "Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04609280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*